Akari Therapeutics Plc Quarterly Accounts Payable, Current in USD from Q4 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Akari Therapeutics Plc quarterly Accounts Payable, Current history and growth rate from Q4 2014 to Q2 2024.
  • Akari Therapeutics Plc Accounts Payable, Current for the quarter ending June 30, 2024 was $5.47M, a 431% increase year-over-year.
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $5.47M +$4.44M +431% Jun 30, 2024 8-K 2024-09-06
Q1 2024 $3.21M Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $5.86M +$2.24M +62% Dec 31, 2023 8-K 2024-09-06
Q2 2023 $1.03M -$604K -37% Jun 30, 2023 6-K 2023-09-29
Q4 2022 $3.62M +$1.83M +102% Dec 31, 2022 8-K 2024-09-06
Q2 2022 $1.63M -$50.4K -2.99% Jun 30, 2022 6-K 2022-09-27
Q4 2021 $1.79M -$1.59M -47.1% Dec 31, 2021 20-F 2023-05-01
Q2 2021 $1.69M -$506K -23.1% Jun 30, 2021 6-K 2021-09-22
Q4 2020 $3.38M +$2.15M +175% Dec 31, 2020 20-F 2022-05-16
Q3 2020 $2.41M +$1.1M +83.3% Sep 30, 2020 20-F 2021-04-21
Q2 2020 $2.19M +$710K +47.9% Jun 30, 2020 20-F 2021-04-21
Q1 2020 $966K -$797K -45.2% Mar 31, 2020 20-F 2021-04-21
Q4 2019 $1.23M -$358K -22.5% Dec 31, 2019 20-F 2021-04-21
Q3 2019 $1.32M Sep 30, 2019 20-F 2021-04-21
Q2 2019 $1.48M -$520K -26% Jun 30, 2019 20-F 2021-04-21
Q1 2019 $1.76M Mar 31, 2019 20-F 2021-04-21
Q4 2018 $1.59M -$385K -19.5% Dec 31, 2018 20-F 2020-03-31
Q2 2018 $2M -$841K -29.6% Jun 30, 2018 6-K 2018-09-27
Q4 2017 $1.97M -$243K -11% Dec 31, 2017 20-F 2019-04-23
Q2 2017 $2.84M +$925K +48.2% Jun 30, 2017 6-K 2017-08-10
Q4 2016 $2.21M -$2.11M -48.8% Dec 31, 2016 20-F 2018-07-18
Q2 2016 $1.92M Jun 30, 2016 6-K/A 2017-04-14
Q1 2016 $625K Mar 31, 2016 10-Q 2016-05-12
Q4 2015 $4.32M +$3.77M +678% Dec 31, 2015 6-K/A 2017-04-14
Q3 2015 $3.75M Sep 30, 2015 10-Q 2015-11-23
Q4 2014 $556K Dec 31, 2014 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.